Beware of Congress Registration & Housing Scams
Study finds PFAS “forever chemicals” may harm fertility, raise preeclampsia risk, and increase preterm birth, highlighting urgent reproductive health concerns.
Federal funding cuts to NIH, CDC, and FDA threaten reproductive health research, patient safety, and access to care, warns new ASRM policy report.
ASRM responds to Trump IVF insurance proposal, urging broader fertility care access and public input on draft coverage rules.
ASRM Center for Policy and Leadership released a report discussing gestational carrier policy in the U.S. discussing it's impact and how lawmakers should proceed going forward.
ASRM supports continued access to mifepristone, warning that unnecessary restrictions could delay reproductive healthcare and harm patients.
ASRM’s Fertility and Sterility series examines restorative reproductive medicine, IVF alternatives, and evidence-based fertility care amid growing policy debate.
ASRM's Office of Public Affairs is running an Instagram campaign highlighting positive IVF stories featuring patients and providers.
ASRM and 19 leading medical societies file an amicus brief urging courts to overturn HHS’s removal of COVID‑19 vaccine guidance for children and pregnant individuals.
SRS, an ASRM affiliate, advocates evidence-based reproductive surgery and full-spectrum fertility care for conditions like endometriosis, fibroids, and PMOS.
ASRM applauds the White House’s first steps toward IVF access but underscores that true equity demands mandatory insurance coverage.
Displaying 911 to 920 of 1649 records
